These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 12195456

  • 1. Is visual field constriction in epilepsy patients treated with vigabatrin reversible?
    Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B.
    J Neurol; 2002 Aug; 249(8):1066-71. PubMed ID: 12195456
    [Abstract] [Full Text] [Related]

  • 2. Vigabatrin retinopathy in an Irish cohort: lack of correlation with dose.
    Kinirons P, Cavalleri GL, O'Rourke D, Doherty CP, Reid I, Logan P, Liggan B, Delanty N.
    Epilepsia; 2006 Feb; 47(2):311-7. PubMed ID: 16499754
    [Abstract] [Full Text] [Related]

  • 3. Binasal visual field defects are not specific to vigabatrin.
    Gonzalez P, Sills GJ, Parks S, Kelly K, Stephen LJ, Keating D, Dutton GN, Brodie MJ.
    Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
    [Abstract] [Full Text] [Related]

  • 4. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study.
    Schmitz B, Schmidt T, Jokiel B, Pfeiffer S, Tiel-Wilck K, Rüther K.
    J Neurol; 2002 Apr; 249(4):469-75. PubMed ID: 11967655
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD, Tocher K, Acheson JF.
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Visual field severity indices demonstrate dose-dependent visual loss from vigabatrin therapy.
    Conway M, Cubbidge RP, Hosking SL.
    Epilepsia; 2008 Jan; 49(1):108-16. PubMed ID: 18184224
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E, Jonsson H, Lappi M.
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [Abstract] [Full Text] [Related]

  • 16. [Visual field changes secondary to vigabatrin treatment].
    Mauri-Llerda JA, Iñiguez C, Tejero-Juste C, Santos-Lasaosa S, Escalza-Cortina I, Ascaso-Puyuelo J, Abad-Alegría F, Morales-Asín F.
    Rev Neurol; 2009 Feb; 31(12):1104-8. PubMed ID: 11205539
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.